Japan’s Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments

By Rocky Swift TOKYO (Reuters) -Japan’s Astellas Pharma said on Monday it agreed to buy U.S. drugmaker Iveric Bio Inc for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmology treatments. The deal marks the fifth major overseas acquisition by Astellas, Japan’s third biggest drugmaker by sales, since 2019…

Read More

World Bank launches more robust, transparent business climate rankings

By Andrea Shalal WASHINGTON (Reuters) -The World Bank on Monday unveiled new methodology and improved safeguards for assessing the business climate in up to 180 countries after embarrassing revelations of data irregularities and favoritism toward China forced it to cancel its flagship rankings two years ago. The bank scrapped its “Doing Business” rankings in September…

Read More

Philippines, China to discuss fishing rights in South China Sea-Marcos

MANILA (Reuters) -Philippines President Ferdinand Marcos Jr said China has agreed to discuss fishing rights in the South China Sea, as he pushed for a “direct communication line” with Beijing on maritime differences. China has agreed to “sit down” and talk about Filipinos’ fishing rights in the South China Sea, Marcos said, adding he has…

Read More

Soft China PMI likely to flow through to uneven commodity demand: Russell

By Clyde Russell LAUNCESTON, Australia (Reuters) -The surprise contraction in China’s manufacturing index in April, coming after first quarter growth exceeded expectations, underlines the uneven nature of the recovery in the world’s second-biggest economy. This variable economic story is likely to be mirrored in China’s imports of major commodities, with strength in some areas being…

Read More